Pertzye Approval History
FDA Approved: Yes (First approved May 17, 2012)
Brand name: Pertzye
Generic name: pancrelipase
Dosage form: Delayed Release Capsules
Company: Digestive Care, Inc.
Treatment for: Pancreatic Exocrine Dysfunction
Pertzye (pancrelipase) is a combination of porcine-derived lipases, proteases, and amylases indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions.
Development History and FDA Approval Process for Pertzye
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.